- Is Cocaine Rehab Aftercare Necessary?
- The Benefit of Relapse Prevention
- Cocaine Abuse is a Chronic Condition
- Continuing Care Options
- Supporting Family and Friends with Cocaine Recovery
What is Cocaine Rehab Aftercare?The concept of aftercare describes the structured, ongoing management of substance abuse recovery following a period of formal treatment - be it inpatient, residential or outpatient. The primary goal of aftercare programs is to teach an individual the skills to persistently cope with environmental cues related to addiction and respond without relapsing to active use.
Is Cocaine Rehab Aftercare Necessary?
Aftercare--the ongoing management of substance abuse recovery after formal treatment--is essential because cocaine addiction is a 'chronic relapsing' disorder.
- Overcoming denial.
- Participation in self-help groups.
- Treating depression.
If you continue to struggle after treatment, help is available by calling 1-888-993-3112Who Answers?. Our treatment support specialists can help you evaluate the need for continued treatment and/or provide more information about aftercare programs for you.
The Benefit of Relapse Prevention
Relapse prevention involves altering behavior so that high-risk situations are avoided and learning how to respond when these situations are inevitably encountered.
- In relapse prevention groups, an addict can address his/her fears of relapse, paying attention to the feedback received from peers.
Relapse prevention has been successful in cocaine-addicted individuals whose depression persists after treatment, a sub-group that usually has poor outcomes and high relapse rates after treatment completion.
Cocaine Abuse is a Chronic Condition
Like other chronic illnesses, such as diabetes, cocaine addiction is a primary, chronic disease of brain, characterized by:
- A disruption in brain reward mechanisms.
- The inability to abstain consistently (from the drug).
- Severe craving, particularly during withdrawal.
- Diminished recognition of significant problems with one's behavior and interpersonal relations.
Unfortunately, addiction is often dealt with as an acute illness that is expected to pass, unlike chronic illnesses, where relapse is ubiquitous and anticipated. This approach only serves to enforce the notion that addiction is a social problem requiring interdiction and law enforcement, rather than a health problem requiring prevention and treatment.
Back in 2000, McLellan and his associates undertook a comparative study of drug dependence with 3 other well-documented chronic diseases:
- Type 1 diabetes
The percentage of patients who relapsed through failure to follow treatment were as follows:
Continuing Care Options
Continuing care refers to treatment programs that cater to individuals after the completion of treatment. Most of these continuing care/aftercare programs consist of counseling, outpatient support groups, and participation in supportive 12-Step programs such as Narcotics Anonymous (NA) or Cocaine Anonymous (CA).
Counseling Interventions and Group Therapy
Since medical treatment for cocaine abuse lags behind that for heroin and alcohol addictions, counseling interventions, and group therapy will continue to play a central role in recovery. Some viable therapies include:
Twelve-Step Facilitation Treatment
Spirituality is frequently cited as a major contributing factor to recovery, usually mediated through Twelve-Step programs.
These fellowships/programs assert the necessity of finding a power greater than ourselves to overcome addiction, and sharing the message with others as a result of a "spiritual awakening" (Alcoholics Anonymous).
The program follows a sponsorship model, where an individual struggling with addiction is able to find support from someone who has experienced the same situation.
Follow-Up Medical Care
There is no FDA-approved treatment for cocaine dependence.
Since many cocaine addicts struggle with co-occurring major depressive disorder, the use of antidepressants such as fluoxetine (Prozac (R)), nefazadone (Serzone (R)) and citalopram (Celexa (R)) has shown significant retention in treatment and reduction in cocaine use.
Additionally, treating underlying depression in cocaine addiction has been demonstrated to improve treatment outcomes.
Ongoing medical treatment follow-ups are warranted for recovering cocaine addicts:
- Whose cardiovascular system has been compromised by heavy cocaine use resulting in heart failure, or myocarditis (infection/inflammation of heart muscle); or
- Who are susceptible to ischemic or hemorrhagic stroke due to heavy cocaine abuse.
A multi-study analysis of CM has demonstrated that, of all the behavioral studies for cocaine dependence, CM has shown the strongest efficacy in treating cocaine addiction, with one study showing a 73% abstinence rate in the first 2 months of treatment.
The effects of CM seem to be enhanced by pharmacotherapy, particularly with antidepressants like bupropion and desipramine; however, more research is required to delineate the magnitude of this correlation.
Sober Living/Therapeutic Communities.
Sober living communities, sometimes referred to as halfway houses, typically receive patients who are not ready for independent living, who do not have a safe home to return to, or who need the support of an environment conducive to recovery.
Sober living options focus on these life skills to allow better reintegration into society after the struggle of addiction is managed.
Therapeutic communities particularly benefit those struggling with the highest severity of addiction, social deviancy, and psychological problems.
Supporting Family and Friends with Cocaine Recovery
Family members are critical to the strength and duration of the client's recovery.
- Both the individual struggling with addiction and their families/friends can benefit from attendance at group meetings set up by many agencies.
- Group-support meetings can enhance relationships by improving communication and reducing stress in families.
- One of the reasons for the improvement in relationships is that these meetings give family members the opportunity to learn more about addiction and co-occurring issues.
- They are able to accurately alter their expectations and learn how to deal with their family members.
- 1976. Alcoholics Anonymous. Third Edition. New York City: Alcoholics Anonymous World Services, Inc.
- Ciraulo, D.A., et al. (2005). Nefazadone treatment of cocaine dependence with comorbid depressive symptoms. Addiction 100(Suppl. 1): 23-31.
- DeLeon, G. (2008). Therapeutic Communities. In Galanter, M., and Kleber, H.D., eds. The American Psychiatric Publishing Textbook of Substance Abuse Treatment. Fourth Edition. Washington, DC: American Psychiatric Publishing, Inc.
- Gingrich, S., and Mueser, K.T. (2011). Illness Management and Recovery: Personalized Skills and Strategies for Those with Mental Illness. Implementation Guide. Dartmouth PRC/Hazelden.
- Hser, Y-I, and Anglin, M.D., 2005. Chapter 20: Drug Treatment and Aftercare Programs. In Coombs, R.H. ed. Addiction Counseling Review: Preparing for Comprehensive, Certification, and Licensing Examinations. Mahwah, NJ: Lawrence Erlbaum Associates.
- James, R.K. (2008). Crisis Intervention Strategies.Sixth Edition. Belmont, CA: Brooks/Cole.
- Julien, R., et al. (2011). A Primer of Drug Addiction. Twelfth Edition. New York, NY: Worth Publishers.
- Kosten, T. R., et al. (2014). Vaccine for Cocaine Dependence: A Randomized Double-Blind Placebo-Controlled Efficacy Trial. Drug Alcohol Depend 140:42-47.
- Landry, M. (1994). Understanding Drugs of Abuse: The Processes of Addiction, Treatment, and Recovery. Washington, DC: American Psychiatric Press, Inc.
- McKay, J.R., et al. (2013). Factors in Sustained Recovery from Cocaine Dependence. J Subst Abuse Treat 45(2):163-172.
- McLellan, A.T., et al. (2000). Drug Dependence, A Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation. JAMA, 284(13):1689-1695.
- Moeller, F.G., et al. (2007). Citalopram Combined with Behavioral Therapy Reduces Cocaine Use: A Double-Blind, Placebo-Controlled Trial. The American Journal of Drug and Alcohol Abuse 33: 367-378.
- Mooney, M.E., Schmitz, J.M., Moeller, F.G., and Grabowski, J. (2007). Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: Two double-blind, randomized, clinical trials. Drug and Alcohol Dependence 88: 214-223.
- NAADAC, (2009). Basics of Addiction Counseling: Desk Reference and Study Guide. Alexandria, VA: NAADAC.
- Neslter E.J., (2004). Historical Review: Molecular and Cellular Mechanisms of Opiate and Cocaine Addiction. TRENDS in Pharmacological Sciences 25(4): 210-218.
- Paczynski, R.P., and Gold, M.S. (2011). Chapter 14: Cocaine and Crack. In Ruiz, P., and Strain, E., eds. Lowinson and Ruiz's Substance Abuse: A Comprehensive Textbook, 5th Edition. Philadelphia: Lippincott, Williams & Wilkins.
- Schmitz, J.M., Averill, P., Stotts, A.L., Moeller, F.G., Rhoades, H.M., and Grabowski, J. (2001). Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug and Alchol Dependence 63: 207-214.
- Schmitz, J.M., Mooney, M.E., Moeller, F.G., Stotts, A.L., Green, C., and Grabowski, J. (2008). Levodopa pharamacotherapy for cocaine dependence: Choosing the optimal behavioral therapy platform. Drug and Alcohol Dependence 94: 142-150.
- Strobe, S., et al., (2013). Spiritual Awakening Predicts Improved Drinking Outcomes in a Polish Treatment Sample. Journal of Addictions Nursing 24(4):209-216.
- Stulz, N. et al., (2011). Psychosocial Treatments for Cocaine Dependence: The Role of Depressive Symptoms. Drug Alcohol Depend 114(1):41-48.
- Substance Abuse and Mental Health Services Administration (SAMHSA). TIP 47. Substance Abuse: Clinical Issues in Outpatient Treatment. Rockville, MD: SAMHSA.
- Vocci, F. J., & Montoya, I. D. (2009). Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Current Opinion in Psychiatry, 22(3), 263-268.
- Walton-Moss, B., et al. (2013). Relationship of Spirituality or Religion to Recovery from Substance Abuse. Journal of Addictions Nursing 24(4):217-226.
- Winhusen, T., et al. (2007). A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Drug and Alcohol Dependence 91: 141-148.